WVXU: Meet the UC doctor trying to change minds skeptical of the COVID-19 vaccine
Louito Edje, MD, says the COVID-19 vaccine is based on years of science
Louito Edje, MD, associate dean of graduate medical education at the University of Cincinnati College of Medicine and UC Medical Center, spoke with WVXU about why she is on a public relations blitz – she was featured in segments on CNBC, TMZ, BET and MSNBC - to change minds about vaccinations for COVID-19. The pandemic is having a disproportionate impact on Black Americans and Edje, a Black female physician, is hoping her participation in the Moderna vaccine trial and her voice may sway some opinions about vaccine safety and efficacy.
After her second dose, Edje was pretty sure she didn’t get a placebo as part of the vaccine trial. "I had a lead arm and it lasted about 24 hours and not much longer than that," Edje told WVXU listeners. "I was able to continue working." She feels fine now and says the risk of being in a trial group was worth it to her because she's lost four family members to COVID-19.
Listen to the WVXU interview with Louito Edje, MD, online.
Louito Edje, MD, seated is shown in the UC College of Medicine Simulation Center. Photo by Colleen Kelley/University of Cincinnati.
Impact Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
German TV highlights UC expert's ancient Maya discoveries
March 2, 2026
The German television show 'Unsolved Case' talks to a University of Cincinnati expert about ballcourts used by the ancient Maya for a program examining how people used spheres as both tools and toys.
UC studies supplement, therapy alternatives to treat depression
March 2, 2026
Media outlets including Cleveland.com and Cleveland's WKYC News highlighted a new University of Cincinnati clinical trial funded by an approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to test two new nonpharmacological treatments for teens and young adults with depression.
'Paradigm-shifting' study confirms effectiveness of long-acting HIV treatment
February 26, 2026
The results of a clinical trial involving the University of Cincinnati, recently published in The New England Journal of Medicine, show people failing HIV treatments with oral medications were able to be treated successfully using injections.